Quote:This is double-edged and is arguably more of a negative than a positive. I.e., if the cosmetic result of a Laviv procedure is unsatisfactory, the patient is stuck with a bad face for several years. This is one of the reasons Sculptra has had very limited commercial uptake despite its being a technically excellent product.
the person that posted that comment has demonstrated absolutely NO understanding of fibroblast cell therapy. lol and to make the comparison to sculptra, sounds like someone needs to go back to biotech school imo.
News 
Market Data 
Discover 
AI
